Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.5 USD | -2.09% | +6.15% | +52.16% |
04:51pm | COVID shots should target JN.1 variants in 2024-25 campaign, US FDA says | RE |
12:38pm | Jefferies Adjusts Price Target on Moderna to $180 From $155, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.16% | 59.28B | |
+41.53% | 40.94B | |
-5.82% | 40.17B | |
-5.56% | 28.69B | |
+10.76% | 26.63B | |
-21.08% | 18.89B | |
+30.00% | 12.46B | |
+1.44% | 12.42B | |
+26.92% | 12.26B | |
-8.50% | 11.42B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing